Clinical Trial Update: Extracellular Vesicles From Mesenchymal Cells in the Treatment of Acute Respiratory Failure [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial is investigating extracellular vesicles derived from mesenchymal cells for treating acute respiratory failure, including severe acute…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia
• Respiratory Distress Syndrome
• Respiratory Syndrome

Snippet

Sponsor: D'Or Institute for Research and Education | Conditions: Severe Acute Respiratory Syndrome (SARS), Acute Respiratory Distress Syndrome (ARDS) | Phase 1, Phase 2 | Status: UNKNOWN